Understanding Long-term Remission Off Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

INTRODUCTION: In antineutrophil cytoplasmic antibody-associated (ANCA) vasculitis, relapse risk and long-term immunosuppressive therapy are problematic. Stopping immunotherapy has not been well described. METHODS: The Glomerular Disease Collaborative Network ANCA vasculitis inception cohort was eval...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Kidney Int Rep
Main Authors: Hogan, Susan L., Nachman, Patrick H., Poulton, Caroline J., Hu, Yichun, Blazek, Lauren N., Free, Meghan E., Jennette, J. Charles, Falk, Ronald J.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2019
Teme:
Clinical Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451087/
https://ncbi.nlm.nih.gov/pubmed/30993230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2019.01.004
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki